ANGLE PLC's (LON:AGL, OTCQX:ANPCY) Andrew Newland speaks to Proactive London after announcing blood donations have restarted to support its US Food & Drug Administration analytical studies, while patient enrolment to its ovarian cancer test has also recommenced.
Newland says he's hoping to complete the work required for the FDA submission in the third quarter subject to the uncertainties caused by the coronavirus lockdown.